Read more about the program (Finnish).
Meet us at the Anglonordic Life Science Conference in London.
Sartar was awarded a Japan patent for use of anagrelide in cancer therapy.
Sartar strengthens the board of directors. CEO of Herantis Pharma, Pekka Simula, has been appointed as a new member to the Sartar Therapeutics board of directors.